Precision Medicine acquires Project Farma

By The Science Advisory Board staff writers

January 15, 2021 -- Precision Medicine has acquired Project Farma, a bioengineering services firm.

Project Farma has led more than a dozen manufacturing facility builds with capital investments greater than $1 billion. The company has been involved in the development of several cell and gene therapy medicines.

The firm will be part of Precision for Medicine, Precision Medicine's research and development services arm.

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter